Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Phase I study commences for topical diclofenac sodium patch

Oct. 9, 2007

Lilly advances atomoxetine to phase II for adult ADHD in Japan

Oct. 9, 2007

Long-acting, nonopiate analgesic drug enters THA trial

Oct. 8, 2007

Positive phase II results reported for Lu-AA-21004 in major depression

Oct. 8, 2007

Orexo adds two new projects to its development pipeline

Oct. 8, 2007

Recent patents disclose novel antipsychotic, antidepressive and anxiolytic agents

Oct. 5, 2007

Novel therapeutic agents for neurological disorders disclosed in recent patents

Oct. 5, 2007

Recent Shionogi patent reports novel agents for cancer pain relief

Oct. 5, 2007

Peptimmune's novel peptide copolymer enters phase I for MS

Oct. 5, 2007

Newron initiates phase II studies for ralfinamide in post-surgical pain

Oct. 4, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...